Equities

Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc

Actions
  • Price (EUR)66.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+22.22%
  • Beta--
Data delayed at least 15 minutes, as of Sep 18 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments465827
Total Receivables, Net177167139
Total Inventory139162120
Prepaid expenses134.126.41
Other current assets, total------
Total current assets375392293
Property, plant & equipment, net899099
Goodwill, net528528579
Intangibles, net2,3212,3422,697
Long term investments------
Note receivable - long term------
Other long term assets5.733.013.27
Total assets3,3183,3543,671
LIABILITIES
Accounts payable396356
Accrued expenses748482
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.492.832.75
Other current liabilities, total2.57112.67
Total current liabilities117161143
Total long term debt1,1261,3471,481
Total debt1,1271,3501,484
Deferred income tax404380445
Minority interest------
Other liabilities, total171824
Total liabilities1,6631,9072,093
SHAREHOLDERS EQUITY
Common stock0.560.550.54
Additional paid-in capital567535516
Retained earnings (accumulated deficit)1,3411,1321,214
Treasury stock - common(220)(189)(134)
Unrealized gain (loss)----0
Other equity, total(34)(32)(19)
Total equity1,6551,4471,578
Total liabilities & shareholders' equity3,3183,3543,671
Total common shares outstanding505050
Treasury shares - common primary issue5.685.174.15
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.